Evidence map›Paper›PMID 22987070›Full record

ArticleNucleic acids research2012

Characterization of human Spartan/C1orf124, an ubiquitin-PCNA interacting regulator of DNA damage tolerance.

Szilvia Juhasz, David Balogh, Ildiko Hajdu, Peter Burkovics, Mark A Villamil, Zhihao Zhuang, Lajos Haracska

Abstract read
In one paragraph

Article in Nucleic acids research, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Szilvia JuhaszInstitute of Genetics, Biological Research Centre, Hungarian Academy of Sciences, Szeged 6726, Hungary.
David Balogh
Ildiko Hajdu
Peter Burkovics
Mark A Villamil
Zhihao Zhuang
Lajos Haracska

Funding

Regulation and specificity of deubiquitylating enzyme complexR01GM097468 · NIGMS · UNIVERSITY OF DELAWARE · PI ZHUANG, ZHIHAO · 2012 to 2016
$1.3M
NIGMS NIH HHS R01 GM097468NIGMS NIH HHS R01GM097468
6 · The paper itself

Abstract

Unrepaired DNA damage may arrest ongoing replication forks, potentially resulting in fork collapse, increased mutagenesis and genomic instability. Replication through DNA lesions depends on mono- and polyubiquitylation of proliferating cell nuclear antigen (PCNA), which enable translesion synthesis (TLS) and template switching, respectively. A proper replication fork rescue is ensured by the dynamic ubiquitylation and deubiquitylation of PCNA; however, as yet, little is known about its regulation. Here, we show that human Spartan/C1orf124 protein provides a higher cellular level of ubiquitylated-PCNA by which it regulates the choice of DNA damage tolerance pathways. We find that Spartan is recruited to sites of replication stress, a process that depends on its PCNA- and ubiquitin-interacting domains and the RAD18 PCNA ubiquitin ligase. Preferential association of Spartan with ubiquitin-modified PCNA protects against PCNA deubiquitylation by ubiquitin-specific protease 1 and facilitates the access of a TLS polymerase to the replication fork. In concert, depletion of Spartan leads to increased sensitivity to DNA damaging agents and causes elevated levels of sister chromatid exchanges. We propose that Spartan promotes genomic stability by regulating the choice of rescue of stalled replication fork, whose mechanism includes its interaction with ubiquitin-conjugated PCNA and protection against PCNA deubiquitylation.

Indexed as

DNA DamageArabidopsis ProteinsCell LineDNA-Binding ProteinsDNA-Directed DNA PolymeraseDNA ReplicationEndopeptidasesHumansProliferating Cell Nuclear AntigenProtein Structure, TertiarySister Chromatid ExchangeUbiquitinUbiquitin-Protein LigasesUbiquitin-Specific ProteasesY-Family DNA PolymerasesArabidopsis ProteinsDNA-Binding ProteinsDNA-Directed DNA PolymeraseEndopeptidasesProliferating Cell Nuclear AntigenRAD18 protein, humanRad30 proteinSPRTN protein, humanUbiquitinUbiquitin-Protein LigasesUbiquitin-Specific ProteasesUSP1 protein, humanY-Family DNA Polymerases

Identifiers

PMID22987070
PMCPMC3510514

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.